secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0001104659-24-001369
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics posts January 2024 investor presentation
---------------------------------------------------------------

- Presentation filed as Exhibit 99.1; covers disease-modifying medicines for neurodegenerative disorders.
- No financial results, clinical data, or guidance changes included in the filing.
- CEO Lisa Ricciardi signed the 8-K; presentation intended for investor discussions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924001369/0001104659-24-001369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924001369/tm2333729d5_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-001369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer